News Starlight Cardiovascular’s Right-Sized Neonatal Stent for Congenital Heart DiseaseJuly 5, 2023 Starlight Cardiovascular Appoints Paul G. Yock, MD to its Board of DirectorsJune 13, 2023 Starlight Cardiovascular Awarded $2.16M NIH SBIR Phase II Grant from NHLBIMarch 22, 2023 A Tried-and-True Innovation Process Applied to Pediatric Congenital Heart DiseaseNovember 1, 2022 Starlight Cardiovascular Secures $9.48M in Series A Financing to Advance Pediatric HealthOctober 4, 2022 Prestigious Annual Pediatric Medical Device Competition Reveals Five FinalistsMay 24, 2022